throbber
Editor: Donna Balado
`Managing Editor: Jennifer Schmidt
`Marketing Manager: Christine Kushner
`
`Copyright © 1999 LippincottW1lliams & Wflkins
`351 West Camden Street
`Baltimore, Maryland 21201-2436 USA
`
`227 East Washington Square
`Philadelphia, PA 19106
`
`All rights reserved. This book is protected by copyright. No part of this book may be re-
`produced in any form or by any means, including photocopying, or utilized by any infor-
`mation storage and retrieval system without written permission from the copyright owner.
`
`The publisher is not responsible (as a matter of product liability, negligence, or otherwise)
`for any injury resulting from any material contained herein. This publication contains in-
`formation relating to general principles of medical care which should not be construed as
`specific instructions for individual patients. Manufacturers’product information and pack-
`age inserts should be reviewed for current information, including contraindications,
`dosages, and precautions.
`
`Printed in the United States ofAmerica
`
`Library of Congress Cataloging-in-Publication Data
`
`Ansel, Howard C., 1933-
`Pharmaceutical dosage forms and drug delievery systems / Howard C.
`Ansel, LoydV. Allen, ]r., Nicholas G. Popovich. —— 7th ed.
`p.
`cm.
`Includes bibliographical references and index.
`ISBN 0—683—30572—7
`2. Drug delivery systems.
`1. Drugs—-Dosage forms.
`Il. Popovich, Nicholas G.
`Ill Title.
`[DNLM: 1. Dosage Forms.
`2. Drug Delivery Systems. QV 785 A618i 1999]
`RS200.A57
`1999
`615’.1—dc21
`DNLM/DLC
`for Library of Congress
`
`1. Allen, LoydV.
`
`99-17498
`CIP
`The publishers have made every efiort to trace the copyright holders for borrowed material. Ifthey
`have inadvertently overlooked any, they will be pleased to make the necessary arrangements at
`the first opportunity.
`
`The use of portions of the text of USP23/NF18, copyright 1994, is by permission of the USP
`Convention, Inc.The Convention is not responsible for any inaccuracy of quotation or for
`any false or misleading implication that may arise from separation of excerpm from the
`original context or by obsolescence resulting from publication of a supplement.
`
`To purchase additional copies of this book call our customer service department at (800)
`638-3030 or fax orders to (301) 824-7390. International customers should call (301)
`714-2324.
`
`99 00 01 O2
`1 2 3 4 5 6 7 8 9 10
`
`Astrazeneca Ex. 2096 p. 2
`
`

`
`
`
`Contents
`
`Preface
`
`Acknowledgments
`
`Section I. PRINCIPLES OF DOSAGE FORM DESIGN AND DEVELOPMENT
`
`I
`
`2
`
`3
`
`4
`
`5
`
`Introduction to Drugs and Pharmacy
`
`New Drug Development and Approval Process
`
`Dosage Form Design: Pharmaceutic and
`Formulation Considerations
`
`Dosage Form Design: Biopharrnaceutic and
`Pharmacokinetic Considerations
`
`Current Good Manufacturing Practices and Good
`Compounding Practices
`
`Section II. SOLID DOSAGE FORMS AND MODIFIED-RELEASE DRUG DELIVERY SYSTEMS
`
`6
`
`7
`
`8
`
`Powders and Granules
`
`Capsules and Tablets
`
`Modified~Release Dosage Forms and Drug Delivery Systems
`
`Section III. SEMI-SOLID AND TRANSDERMAL SYSTEMS
`
`_
`
`9
`
`TO
`
`Ointments, Creams, and Gels
`
`Transdermal Drug Delivery Systems
`
`v
`
`vii
`
`1
`
`23
`
`60
`
`101
`
`142
`
`164
`
`179
`
`229
`
`‘244
`
`263
`
`ix
`
`Astrazeneca Ex. 2096 p. 3
`
`

`
`X
`
`Contents
`
`Section IV. PHARMACEUTICAL INSERTS
`
`II
`
`Suppositories and Inserts
`
`Section V.
`
`LIOUID DOSAGE FORMS
`
`I 2
`
`I3
`
`Solutions
`
`Disperse Systems
`
`Section VI. STERILE DOSAGE FORMS AND DELIVERY SYSTEMS
`
`T4
`
`T5
`
`T6
`
`Parenterals
`
`Biologicals
`
`Ophthalmic Solutions and Suspensions
`
`Section VII. NOVEL AND ADVANCED DOSAGE FORMS, DELIVERY SYSTEMS, AND DEVICES
`
`Radiopharmaceuticals
`
`Products of Biotechnology
`
`Novel Dosage Forms and Drug Delivery Technologies
`
`Systems and Techniques of Pharmaceutical Measurement
`
`T7
`
`T8
`
`T9
`
`Appendix
`
`Index
`
`279
`
`296
`
`346
`
`397
`
`450
`
`469
`
`487
`
`503
`
`535
`
`552
`
`563
`
`Astrazeneca Ex. 2096 p. 4
`
`

`
`Section V. Liquid Dosage Forms
`
`
`
`SOLUTIONS
`
`
`
`Chapter at a Glance
`
`Solubility
`Inorganic Molecules
`Organic Molecules
`Some Solvents For Liquid Preparations
`Distillation Method
`
`Ion-exchange method
`Reverse Osmosis
`
`Preparation of Solutions
`Oral Solutions and Preparations for Oral
`Solution
`
`Dry Mixtures for Solution
`Oral Solutions
`
`Oral Rehyclration Solutions
`Oral Colonic Lavage Solution
`Magnesium Citrate Oral Solution
`Sodium Citrate and Citric Acid Oral Solution
`
`Syrups
`Components of Syrups
`Sucrose and Non-Sucrose Based Syrups
`Antimicrobial Preseroatioe
`I-‘laoorant
`Colo:-ant
`Preparation of Syrups
`Solution with the Aid oft-teat
`Solution by Agitation zoitlront the Ala‘ of
`Heat
`
`Addition of Sucrose to a Medicated Liquid or
`to a Flavor-ea‘ Liquid
`Percolation
`Elixirs
`
`Preparation of Elixirs
`Norunedicated Elixirs
`Medicated Elixirs
`Arztlhistarnine Elixirs
`
`Barlriturate Sedatioe/Hypnotic Elixirs
`Phenobarbital Elixir
`
`Digoxin Elixir
`Tinctures
`
`295
`
`Proper Administration and Use of Liquid
`Perot-al Dosage Forms
`Topical Solutions and Tinctures
`Topical Solutions
`Sprays
`Alumirturn Acetate Topical Solution
`Aluminum Subacelale Topical
`Solution
`
`Calcium Hydroxide Topical Solution
`Coal Tar Topical Solution
`Hydrogen Peroxide Topical Solution
`Cnlorlrexidine Gluconale Solution
`
`Pooi:ione—loa'ine Topical Solution
`Thirnerosal Topical Solution
`Vaginal and Rectal Solutions
`Vaginal Douche-5
`Retention Enernas
`Evacuation Enernas
`
`Topical Tinctures
`Iodine Tlncture
`
`Compound Benzoin Ttncture
`Thirnerosal Tincture
`
`Special Application Solutions
`Nasal Preparations
`Nasal Decongestant Solutions
`lnlzalation Solutions
`
`Examples of Medicated inhalation
`Solutions
`Inltalants
`
`Arnyl Nitrite lnltalonl
`Propylhexedrine lnltalant
`Proper Administration and llse of Nasal
`Drops and Sprays
`Nasal Routefor Systemic Effects
`Otic Solutions
`
`Cerumert-Removing Solutions
`Antz‘—infectloe, Anti-inflammatory, and
`Analgesic Ear Preparations
`
`AstraZeneca Ex. 2096 p. 5
`
`

`
`Solutions
`
`29'?’
`
`Propcraidminislration and use qf Dtic
`D"P5
`Topical Oral (Dental) Solutions.
`Miscellaneous Solutions
`Aromatic We lets
`Diluted Acids
`irits
`
`onaqueous “Solutions
`
`Lmime’'
`nts
`Collodions
`Collodion
`
`Flexible Colladfon
`
`_ Salicylic Acid Coiiadion
`Extraction Methods for Preparing
`Solutions
`Methods of Extraction
`Maceratiort
`Percolation
`
`Example Preparations Prepared by
`Extraction Processes-
`Fluidextracta
`Extracts
`
`IN rI~orstcot:H1=.~ocAL tem1s,solul:io11s maybe pre-
`pared from any combination of solid, liquid. and
`gas, the three states of matter. For example, a solid
`solute may be dissolved in either another solid, at
`liquid, oragas, aridtvifltthesamebeiltgmie fora
`liquid solute and for a gas. nine types of homoge-
`neous mixtures arepossilaleln pharmac}-,howeve1;
`interest insolutions is for the most part
`to
`_prepa.ral:ions of a solid, a. liquid. and less Itequently
`a gas solute dissolved in a liquid solvent.
`In pharmaceutical henna. solutions are "liquid
`preparations that contain one or more chemical
`substances dissolved in a suitable solvent or tl."I:l.'lt-
`tute of mutually miscible solvents” (11. Because of a
`particular pharmaceutical solutiorfs use, it may be
`clessitied as an and solution. otic solution. ophthaipu'c
`solution, or topical solution. Still O‘tl1ersolutions,l:e-
`causa of their composition oruse. maybeclassified
`as other phamaceutical dosage forms For oom-
`ple. aqueous solutions containing a sugar are clas-
`sified as syrups; sweetened hydroalcoholic (combi-
`nations ofwater and ethanol} solutions are termed
`elixirs; solutions of aromatic materials" are termed
`mi:-itsifthesotventis alcol-nolicot orantalicwafetsif
`the solvent is aqueous. Solutions prepared by cat-
`tracting active constituents from crude drugs are.
`ternned.
`orflttfd extracts dependingon their
`method of preparation and their concentration.
`Iinctum may also be solutions of chemical sub-
`stances dissolved in alcohol orin a ltydroalcoholic
`so'1vent.Certainsolnlions preptuedtobesteriieand
`pytogan-fiee and intended for parenteral .adminis-
`tration are classified as injections. Although other
`ezatarnples could be- cited, it is apparent that asolu-
`tion, as a distinct type of pharmaceutical p'oepa.'ta-
`tion, is rtmch further defined than is the physico~
`chemical definition of the term solution.
`Oral solutions. syrups, elixirs, spirits and tinc—
`lures are prepared and used tor the specific effects
`of the
`agents present. In these prepara-
`tions, the medicinal agents are intended to provide
`
`systemic effects-.'.[‘he fact that they ate adrninistetad
`in solution form usually means that their absorp-
`tion from the gastrointestirtal tract into the sys-
`temic circulation maybe expected to occur more
`rapidly-than fiom-suspension or solid dosage forms
`of the same rrioiiicinal agent.
`Solutes other than the medicinal agent are usu-
`ally present in orally
`solutions.T_hese
`azdditional agents usually are included to provide
`color, flavor, sweetness, or stability to the solution.
`In formulating -or compounding a phartnaceulical
`solution, the phannadst must utilize ‘l.t1.§CI1'l'.I'lafiDrl
`on the solubility and stability of each of the solutes
`pment with regard to the solvent or solvent sys-
`tem employed. Combinations of medicinal or
`pharmaceutic agents that will result in Chomical or
`physical interactions affecting the therapeutic qual-
`ityorphannaceuticstalztilityofthe product muatbe
`avoided.
`For single-solute solutions and especially for
`multiple-solute solutions, the pharmacist must be
`aware of the solubility
`of the solutes
`and the features of the common pharrnaccufical
`solvents. Each chemical agent has its own so1ubil~
`ity in a given solvent. For many medicinal agents,
`theirsolubilities in the usual solvents are stated in
`the USP aswellas in other reference books.
`
`‘Solubility
`Attractive forces between atoms Ieadto the for-
`mation of molecules and ions. The intennol'ecui|ar
`forces, which are developed between like mole—
`cules, are responsible for the pl-grsical state (Le-.,
`solid. liquid, or gas} of the substance under‘ given
`conditions, as temperature and pressure-.Under or-
`dinary conditions, most organic compounds, and
`thus most drug substances. form molecularsolids.
`When molecules interact, attractive foroes and re-
`pulstveton:esareine.tlect.?l'he attract-iveforcescause
`the molecules to cohere, whereas the repulsive
`
`Astra.Zeneca Ex. 2096 p. 6
`
`

`
`198
`
`Solmforrs
`
`£0105 prevent molecular mretpenetz-stion and de-
`struction. When Ihe attractive and repulshre forces
`areequal, the potential energybetweentwo1:nole—
`culesisminimumandthesystemismoststable.
`Dipolar molecules frequently tend to align
`themselves with other dipole! molecules such that
`the negative pole of one molecule points toward
`the positive pole of the other. Large groups of mol—
`ecules may be associated through these weal: at~
`lractions known as dipole-dipole or van do" Waals
`foroesln addition to the dipolarinteraclions. other
`attractions occur].-retween polar and nonpolar mol-
`ecules and ions. The include ion-dipole forces
`-and hydrogen bonding. The latter is of particular
`interest. Because of small size andlarge electrosta-
`ticfield. the hydrogen atomcarunoveirl closetoan
`electronegative atom. forming an clectrostafic type
`of association referred to as a hydrogen bond or hy-
`drogen bridge Hydrogen bonding involves“ strongly
`electronegatlve atoms as oxygen. nitrogen. andflu—
`orine. Such a bond exists in water, represented by
`the dotted lines:
`
`__
`H..:°~,,_
`'-/(Kl
`
`Hydrogen bonds also moist between some alcohol
`molecules, esters, carboxylic acids, aldehydes, and
`polypeptides.
`When a solute dissolves, the substances inter-
`molecular forces of attraction must be overcome by
`forces of attraction between the solute and solvent
`
`molecules.Thisinvo1ues breakirlg the solute-solute
`forces and the solvent-solvent forces to achieve the
`solute-solvent attractlort
`
`The solubility of an agent in a particular -solvent
`indicates the mdrinnnn ooncenlrtltion to which a
`solution may be prepared with that agent and that
`solvent. When a solvent, at it given tempetahjre,
`hasdissolvedall oflhe solute it can, itis said tube
`saturated. To emphasize the possible variation in
`solubility between two chemical agents and titers-
`fore in the amounts of each required to prepare a
`saturated solution. two oficial aqueous. saturated
`solutions are cited as examples, Calcium Hydroxide-
`Topical Solutictn, USP, and Fotassium Iodide Oral
`Soluiiort. USF‘. The first solutiotr. prepared l:'y.agi-
`
`tadngan excess amount of calcium hydroxide with
`purified water, contains only about 140 mg of dis-
`solved solute per 100 ml. of sol1_.1l:i.o_n at 25°C,
`whereas the latter solution contains about 100 g of
`solute per 100 ml. of solution, over 700 l:'m1es.as
`much solute as
`in the calcium hyrlroadde
`topical solution. It is apparent Erom this compari-
`son that the rnaximurn possible concentration to
`which a phamiacist niayprepare a solution varies
`greatly and is dependent in par.t,.oIr1 the chemical
`consfitufion of the solute. Through selection of a
`diffiexenl solubilizing agent or a difierent chemical
`salt form of the medicinal agent, alteration of H::.e
`pH ofa solution, or substitution, in part or in whole,
`of the solvent, a ph_armac'ist csninccrtain instances
`dissolve 9-eater -quantities of a solute than would
`otherwise be possible. For example, iodine gren-
`ules are soluble in water only to the extent ofl g
`in about 3000 mL of water. Using only these
`two agents. the maximum concentration possible
`would be approxirnately D.03% of iodine in aque-
`ousaolution.However. through the use otan aque-
`ous solution of potassium or sodium iodide as the
`solvent. much larger amounts ofiodirte may be dis-
`solved as the result of the formation of-a water-
`
`soluble complex with the iodide salt.'1'hi.s reaction
`is taken .acl:I-outage of, for example, in Iodine Topi-
`cal Solution, USP, prepared to contain about 2% of
`iodine and 2.4% ofsodium iodide.
`
`Temperature is an imponant factor’ in cIetem'Ii’n-
`ing the solubilityofa drugand inpreparingits so—
`lution. Most chemicals absorb hear when they are
`dissolvedand-aresaid to have apositfoe heat ofa'o-
`lsrtiou, resulting in increased solubility with an in-
`crease in temperanu-e.A few chemlcals have a stage
`arise hem‘ of solution and exhibit -a decrease in
`solubility with a rise in temperature. Other factors,
`in addition to
`effect solubility. These
`include the vmious chemical and other physical
`properties ofboth the solute and the solvent, fic-
`tors of pressure, the acidity or bmicity-of the solu-
`tion, the state of subdivision of the solute, and the
`physical agitation applied to the solution during
`the dissolving process. The solubility of a pure
`chemical substance at a given temperature and
`pressure is oonstant: however, its mic qfsolution,
`thatis. the speedatwhichit dissolves, depends on
`thcparticlesize ofthesubstanceandthe extlentof
`agitation.'I'he finer the powder. the greater the sur-
`face area that comes in contact with the solvent,
`and the more rapid-the dissohlingprocessllklso. the
`greater die agltatiort. the more unsaturated solvent
`passes over the drug, and the faster the formation
`of the solution.
`
`AstraZeneca Ex. 2096 p. '7
`
`

`
`solvent-
`The solubility of a. 5u|::sI:a11oe in a
`may be determined by preparing a saturated solu-
`tion of itat a specific temperature and determining
`by chemical analysis the amount of chemical dis-
`solved in a given weight of solution. By simple cal-
`culation, the amount of solvent required to dissolve
`the amount of solute can be determined.The solu-
`bility may then be expressed as gains ofsolute disr
`soivingin milliliters ofsolvent—for examplefl g-of
`sodium chloride dissolves in 2.8 ml. of water.’
`When theexaetsohibilityhasnot been determined,
`general expressions of relative solubility may be
`1.I.sed."Ihese terms. are defined in the USP as pre-
`sented inTabIe 12.1 [2]-
`Agreatmanyoftlie important orgsnicmedicirnal
`agents are either weak acids or weal: bases, and
`their solubilityis dependent to a large measure on
`thepl-I oftl1eao1vant.Ti-iese drugs react either with
`strong acids -or strong bases to form water-soluble
`salts. For instance, Ehe weak bases, includingmany
`of the alkaloids (atropine, codeine, and niorphine),
`arttlhistarrtines (dm e and tn‘pelen-
`namlne), local anesthetics (cocaine, procaine, and
`tetracaine), and otlreritrtportant drugs are not very
`weter-soluble, but they are soluble in dilute solu-
`tions of acids.
`manufacturers have
`prepared many acid salts of these organic bases to
`enable the preparation of aqueous solutions It
`must be recognized, however. that if the pH of the
`aqueous solutions of these salts is changed by the
`addition ofalkali, the free base may separate from
`solution unless it has adequate solubilityin water,
`Organic medicinals that are weak acids include the
`barbimtate drugs (as phenobarbital and pentobar-
`bitali and the sulfonainides (as sultadiazine and
`sulfacetemide). These and other weak acids form
`water-soluble sales in basic solution and maysepa-
`rate from solution by a lowering of the pH. Table
`1522 presents the colnparative solubilities of sortie
`typical examples-oiweak acids and weakbases and
`their salts.
`
`Table 12.1. Relative Terms of Solubility {II
`
`Elesoiplhzlenn
`
`Very soluble
`Freeiy soluble
`Soluble
`Sparlngly -soluble
`Slightlysoluble
`Very slightly soluble
`Practically insoluble
`or insoluble
`
`Parts ofsoforlrl Reqnked
`for 1 Part ofsolute
`
`Less than 1
`Front 1 to m
`From ‘it! to 30
`From 30 to 100
`From1.00to1OOI1
`From into to 1o,mo
`10,000 and over
`
`Solutions
`
`199
`
`Table 122. Water and!)-leohol Solulailit-ies of Home
`Selected Weak Acids, Weak Eases, and ‘Their Salts
`
`Number ofml. ofsalolrnt
`Rovuttrad to Dissalw
`1 so‘ the
`Alcohol
`
`Witter
`
`455
`0.5
`120
`an
`2.5
`5,000
`16
`1,000
`:1
`200
`1
`13.000
`2
`
`2
`5
`2
`1,280
`325
`210
`5:55
`B‘
`1D
`soluble
`15
`sparingly soluble
`slightly soluble
`
`Drug
`
`Atropine
`Atropine sulfate
`Codeine
`-Codeine sullate
`Codeine phosphate
`Morphine
`Morphine sulfate
`Phenobarbital
`Phenobarbital sodium
`Procaine
`Pi-oczine hydrochlotide
`Sulladiaaine
`Sodium aulfadiaeine
`
`Although there are no exact rules" for predicting
`unerringly the solubility of a chemical agent in a
`particular
`liquid, experienced pharmaceutical
`chemists can estimate the general solubility of a
`chemical compound based on its molecular struc-
`ture and functional groups.Tl1e infiormadon gath-
`ered on a great number of individual chemical
`compounds has led to the characterization of the
`solubilities of groups of compounds, and though
`there-may be an occasional inaccuracy with respect
`to an individual member of a group of compounds,
`the generalizations nonetheless serve a useful
`function.As demonstrated by the data in‘1hb1e 12.2
`and other similar data, salts of organic‘ compounds
`are more soluble in water than are the correspond-
`ing organic bases. Conversely, the organic bases are
`more soluble in organic solvents.
`than are the corresponding salt forms. Perhaps the
`most written guideline for the prediction of solu-
`bilityis l:l:1at”like dissolves lll':E,"mEal‘lfl'1g that a sol-
`ttenthfivingachemlcalstruchiremostsimilarto
`tliatofthe intended solutewillbe most likely to
`dissolve it.Thus, organic compounds are more sol-
`uble in organic solvents than in water. Organic
`compounds may, however.‘ be somewhat water-
`Suluble if they contain polar groups capable of
`loaning hydrogen bonds with water. In fact. the
`greater the number of polar groups present. the
`greater will likely be the organic compounds solu-
`bility in water. Polar groups include 0H. CH0.
`COPL CHOH4 ('_‘H3OH.- C001-I, NO, C0, NH,‘
`and S051-l.'I'he introduction of halogen atoms into
`
`Astraleneca Ex. 2096 p. 8
`
`

`
`3011
`
`Solutions
`
`a molecule tends to decrease water-solubil:lty be
`cause of an increase in the molecular weight of the
`cornpouncl without a proportionate increase in po-
`larity.Anincnease inthe molecular weight of an or-
`ganic compound without a change in polarity re-
`sults in decreased solubility in water. Table 12.3
`demonstrates some of these generalities through
`the use of specific chemical examples.
`As with organic compounds, the pharmacist is
`aware of some general patterns of solubility that
`apply to inorganic compounds. For instance, most
`salts of rnonovalent cations such as sodiulzn, potas-
`sium. and ammonium are water soluble, whereas
`the divalent cations like calcium. magnesium, and
`barium usually form water-soluble compounds
`with nitrate, acetate, and chloride anions but not
`with carbonate. phosphate. or hydrozdde
`‘lb
`be sure. there are certain combinations of anion
`arid cation that would seem to be similar in make-
`
`up but that do not have similar solubility character-
`istics. For instance, magnesiumsulfate (EPSDtl'l salt)
`is soluble, but calcium sulfate is only slightly solu-
`ble; barium sulhte isveryinsolubie (1 gdiesolves in
`about 400,000 mL of water) and is used as an
`opaque media for x-ray observation of the intesti-
`nal tract, but barium sulfide and barium sulfite are
`notasinsoluble, and theirora1usecanresultinpoi-
`sorting; rnercurous chloride Cl-_IgCl) is insoluble and
`was founerly used as a cathartic, but mercuric chlo-
`ride (HgCL_,) is soluble in waterandisa deadlypoi—
`son if taken lute-mall'y.‘1‘here are many instances in
`which solubilitias of certain drugs and their differ-
`entiation from other drugs are critical to the phar-
`macist in order that he or she might avoid com-
`pounding failures or therapeutic disasters.
`
`Table '12-3. Solubillties of Selected Organic
`Compounds in Water as a Demornslralion-of
`Chemical Structure-Solubility Relationship
`
`Compound
`Benzene
`Beuzoic acid
`Benzyl alcohol
`Phenol
`P-yroeatech ol
`1’rr°s111°1
`Carbon tetrachloride
`Chloroforrn
`Methylene chloride
`
`Formula
`QH.
`Cal-_l,CCIOH
`c,H,cH,o1-I
`Cg}-I503
`C‘!-I, (OI-D,
`C¢Hz(0H3a
`CC),
`CPICI3
`t:H,c1,
`
`Number ofml.
`oflrlrhtrr
`Required to
`Dissolve I gqf
`Compound
`1430
`1?5
`25
`15 _
`2.3
`17
`zooo
`200
`so
`
`For organic as well as for inorganic solutes, the
`ability of a solvent to dissolve them depends on
`its effectiveness in overcoming the electronic
`Forces that hold the atoms of the solute together
`and the corresponding lack of resolute on the
`part of the atoms themselves to resist the -solvent
`action. During the dissolution process, the mole-
`cules of the solvent and the solute become
`
`uniformly mixed and cohesive forces of the atoms
`are replaced by new forces due to the attraction
`of the solute and solvent molecules for one
`another.
`
`The student may find the following general rules
`of solubility useful.
`
`Inorgrlnic Molecules
`1. lfbotlt the cation and anion ofan ionic oom-
`pound are monooalent, the solutessolute attrac-
`tive foroes are usually easily overcome, and
`therefore, these compounds are generally water
`soluble. (Examples, Nacl, LiBr, 1:1, NH,No,,
`NaNO,)
`2. Ifonlyone ofthetwo ions in an ionicoom-
`pound
`the solute—solute interac-
`tions are also usually easily overcome and the
`compounds -are water soluble.
`(Examples:
`Baal! M31a.Nez50« NaaP04J
`3. Ifboih the cationand anionare multitJeI'ent, the
`solute-solute interaction maybe too great to be-
`overcome by the solute-solvent interaction
`and the compound may have poor water solu-
`bility. (Examples: C2330‘, BaSO,,, BiP0,: Ex-
`ceptions: Z1150‘, Fe-S0,.)
`4. Common salts of alkali-rnetals (Na, K, Li, :2,
`R13) are usually water soluble.
`(Exception:
`“$303)
`5. Ammonium and quaternary ammonium salts
`are water soluble.
`IS. Nitrates. ttltrites, acetates, chlnrates, and lac-
`tates are generally water soluble. (Exceptions:
`silver and Inercurous acetate)
`'1'. Sulfates, sulfates, and thlosulfates are generally
`water soluble. (Exceptions: calcium and bar-
`ium salts)
`8. Cl1lorides,. bromides, and iodida are water
`soluble. (Exceptions: salts of silver and mer-
`curousions)
`9. Acid salts. corresponding to an insoluble alt
`will be more water soluble than the original
`salt.
`
`10. I-Iydroxides and oxides of compounds other
`than alkali metal cations and the arnmoniurn
`
`water insoluble.
`
`Astrazeneca Ex. 2096 p. 9
`
`

`
`Solctiavls
`
`301
`
`11. Sulficles are water insoluble except for their
`alltali metal salts.
`
`12. Phosphates, carbonates, silicates isolates, and
`hypochlodtes are water insoluble except for
`their alkali metal salts and amrnonlum salts.
`
`Some Solvents For
`
`Liquid Preparations
`
`Thefoflowixigagerltsfirtduseassolwzentsin the
`preparation of solutions.
`
`Organs’: Molecules
`
`‘.l. Molecules having one polar functional group
`are usuallysoh1ble.tototalcl1ai11Ie.ngtlzs offive
`carbons.
`'
`
`2. Molecules having branched chains are more
`soluble than the cmresponding Stra1'g;l1t-chain
`compound.
`3. Vi-hear solubility decreases ‘with an increase in
`molecular weight.
`4. Increased structural similarity between solute
`and solvent is accompanied by increased solu-
`bility.
`
`It is the pham-uacist's knowledge of the chemical
`characteristics ofdrugs thatpermits the selection of
`the proper scilvent for a particular solute. However;
`in addition to the factors 0! solubility, the selection
`is based on such additional solvent characteristics
`
`as "clarity, low toxicity, viscosity, compatibility with
`other forntulative ingredients. chemical inertness.
`palatability, odor. color, and economy. In most in-
`stances. and especially for solutions to be taken
`orally, used ophlhalmically, or inieclecl, waleris the
`preierred solvent because it comes closer to meet-
`irtg the majority of the above criteria than the other
`available solvents. in many instances, when water
`is used as the primary solvent, an auxiliary solvent
`is also employed to augment the solvent action of
`water or to contribute to a product's chernical or
`physical stability. Alcohol, glycerin. and propylene
`glycol, perhaps the most used.
`solvents,
`have been quite eifective in contributing to the de-
`sired characteristics of pharmaceutical solutions
`and in maintaining their stability.
`Otlter solvents, such as acetone. ethyl mode, and
`isopropyl alcohol. are too toidc to be permitted" in
`phannaceutical preparations to be taken inte.-.11al1y,
`btlttheyareusefulasrcagentsolvenlsinotganlc
`cherrllsl-ry and in the preparatory stages of drug cle-
`veloprnent, asin the exliacfionorremoval ofactivle
`-oorstiruents from medicinal plants. For purposes
`such as-this, cenairisolventsareofficlallgrrecognlzed
`irithecoInpe:ndia.AnL:mbero£fixedoils,5uchas
`cornoil, cottonseeclofl, peanut oiJ.,andsese1ne-oil,
`serve usefill solvent functions particularly in the
`preparation of oleaginous injections and are recog-
`nlzedin the officialcompendla Eorthisputpose.
`
`Alcohol. use (Ethyl Alcohol,
`Ethanol, c,H5oH)
`Next to warm; alcohol is the most useful solvent
`inphannacjcltisuseclassprimarysolventfcr
`many" organic con1pounds.'Ibgether with water it
`forms a 1-ryclroalcoholic mixture that dissolves both
`alcohol-soluble and water-soluble substances, a
`feature especially useful in the extraction of active
`corlslituents from crude drugs. Byvarying the pro-
`portion of the two agents, the active constituents
`may be selectively dissolved and extracted or al-
`lowed to remain behind according to their particu-
`lar solubility characteristics in the rncnstruum. Al-
`-cohol. USP. is 9-L9 to 96.0% Czl-1501-I by wailtune
`[leg Viv) when determined at l5.56"'C, the U.S.
`Government’s standard temperature fior alcohol
`detenrninatlons. Dehydrated Alcohol, USE contains
`not less than 99.5% Q1!-l5OH byvolnme and is uti-
`lized in instances in whichan essentially water-free
`alcohol is desired.
`
`Alcohol has been Well recognized as a solvent
`and encipient in the formulation of oral pharma-
`ceutical products. Certain drugs are insoluble in
`water and must be dissolved in an alternate vehi-
`cle. Alcohol is often preferred because of its misci-
`bility with water and its ability to dissolve mam
`water—insolubIe ingredients, including drug sub-
`stanoes, ilavorants, and antimicrobial preservatives.
`Alcohol Is frequently used with other solvents, as
`glycol: and glycerin, to reduce the amount of alco-
`holrcquired. ltalso isusedin liquid produclsas an
`antiinicrobial preservative alone one a copaeserv-
`some with parabans, benzaoalasp sorbatess, and other
`agents.
`l-iowevaer, aside from its pharmaceutic advan-
`tages as a solvent and preservative, concern has
`been expressed over the undesired phannacologic
`andpotentlal toxic effects of alcohol wheningested
`in phannaceuxical products particularly by child-
`ren.Thus, the FDA has proposed that -
`ers of OTC oral drug products restrict, insofar
`aspossible, the use of alcohol and include appro-
`priate warnings in the labeling. For OTC oral prod-
`ucts intended for cldldren under 6 years of age, the
`recommended alcohol-content limit is 0.5%; liar
`products intended for children 6 to 12 years of age,
`the recommended limit is 5%; and for products
`
`Astraleneca Ex. 2096 p. 10
`
`

`
`392.
`
`Soiutiolts
`
`Ireuommendedfornhildxen over123/ears ofsgesnd
`for acl1.Il1s,'the recommended limit is 10%-
`
`Diluted Alcohol, NP
`
`Diluted .Alcol'1ol.NF, is prepared by'I:cu'xir\g equal
`volumes of Alcohol. USB and Purified VVatel'. USE‘.
`The finalvohinte cci-suchrnixturesisnotthesurn of
`the individual irolumesof the two components, but
`duenooontraction oitheliquirkupon mixir|g,tl-1e fi«
`nalvolumeis gerrerullyab0'ut39b1essthanw'hut
`would normally be expected. Thus when 50 mt. oi
`each component "is combined, the resulting product
`measures approximately 97 mi... It is for this reason
`that the strength of Diluted Alcohol, NE is not ex-
`actlyhalfthat ofthe more concentrated alcohol, but
`slightly greater: 1PP“3'X5n'|ateI}' 4996. Diluted alcohol
`is a useful ltyllroalcoholic solvent in various phar-
`maceutical processes and preparations.
`
`Aicatwl, Rubbing
`
`Rublririgiklcohol contains about 70% ofethyl el-
`coho! by volume, the remainder consisting ofwu—
`ter, denaturantswith orwitiiout color additives and
`perfume oils, and stabilizers. In each 100 ml.., it
`must contain not less than 355 mg of sucrose oc-
`taacetate or 1.4 mg of denatonium benzoate, bitter
`substances that discourage accidental or abusive
`oral ingestion. The dsnahirants employed in rub-
`bing alcohol are according to the Internal Revenue
`Service, US». Treasure Department, Formula 23-I-I,
`which iscomposed of 8 parts byvotume of acetone,
`1.5 parts byvolurne of:nethy1isobutyllr.etone,sr|_d
`100 parts byvolume of ethyl alcoholfllie use otthis
`denaturant mixture makes the separation of ethyl
`alcohol from -the denahirants avirtually itnpossible
`task with ordinary distillation apparatus. This dis-
`courages the illegal removal and use as a beverage
`of the alcoholic content of rubbing alcohol.
`The productisvolatile and flammable and should
`be stored in tight oontairrers nemote from Ere. It is
`employeclas anibefacient extemsilyand asa sooth-
`ing mb for bedfidden-patiems, agennicide tor in-
`struments. andaslcin cleanserptiortoinjection. Iris
`3150135211 asavehiclefortopicalpreparafions.
`Synonym: Alcohol Rubbing Compound-
`
`GI-year-in, IISP {GIyceraI):
`CH3.OH- CHOH' C'H2_OH
`
`Glycerin is it clear syrupy liquid with a sweet
`taste, It is miscflzlle both with waterand alcohol. As
`a sohrent, it is comparable with alcohol, but because
`
`of ilsvisoosity, solutesare slowtysotuble initunless»
`it is tenderer! lm viscous hyheefing. Glycerin has‘;
`preservative qualifies and is often used as a stabs.
`lizerandas an auxiliary solventin conjunction with.
`watetora1oohDLItisusedinmanyintemal prepay:
`rations.
`
`Isapropyl R-ulJbingAlcoiro!
`
`lsopropyl Rubbingfilccd-tol is about 70% by-val.
`urns isopropyl-alcohol. the remainder consisting of
`water with or without color additives. stabilizers,
`and perfurne oils. It is used'e>'ctemel1y as a rubetas
`dart and sootl1i.ng.rub and as a vehicle for topical
`products. This preparation and a commercially
`available 91% isopropyl alcohol solution are com-
`monly employed by diabetic patients in preparing
`needles and
`fiorhypodennic injections of
`
`1nsuJ1n'' and to: disinfecting the skin.
`
`Propylene Glycol, USP,
`ch,cH(0rDcH,oH
`
`Propylene glycol, a viscous liquid, is miscible
`with water and aloo11oI.1t is a useful solvent with a
`
`wide range ofapplications and is frequently substi-
`tuted for glycerin in modern pharmaceutical for-
`mulations.
`
`Purified Water, use, H20
`
`Naturallyoucuningwaterexertsitssolvent ei3FEC‘l’
`on most substances it contacts and thus is-impure
`and contains varying amounts of dissolved inor-
`prlic salts, usually sodium. potassium, calcium,
`magnesium, and iron, chlorides, sulfates, and bi-
`carbonates, as well as dissolved and undisrolved
`organic matter and microorganisms. Water found
`inmost cities andtowns where water is-purified for
`diinltingpiri-poses usually contains less than 0.1%
`oftotal solids, delnennined by evaporatinga 100 mL
`ample of water to dryness and weighing the
`residue {which would weigh less than 100' mg).
`Drinking water must meet the United States Pub-
`lic Health Service regulations with respect to bac-
`tcrioiogical purity. Acceptable dfinldng water
`should be clear, colorless. odorless, and neutral or
`only slightly acid or alkaline, the deviation from
`ncutral'bei:ttgdueto tlienatureofthedissolved
`solids and gases [carbon dioxide r.onn:ibut

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket